Difficulty: Medium
Average Score: 63%
Practice
Clofibrate (Atromid-S) is generally regarded as superior to gemfibrozil.
Correct answer
B
Rationale
In the context of pharmacology across the lifespan, understanding the differences between medications like clofibrate and gemfibrozil is crucial for safe and effective patient care. The correct answer, B) FALSE, is supported by current evidence and clinical practice. Clofibrate (Atromid-S) is not regarded as superior to gemfibrozil.
Clofibrate has fallen out of favor due to safety concerns and limited efficacy compared to newer lipid-lowering agents. Gemfibrozil, on the other hand, is a more commonly prescribed fibrate that has shown better outcomes in terms of reducing triglycerides and increasing HDL cholesterol levels.
Option A) TRUE is incorrect because it incorrectly states that clofibrate is superior, which is not supported by current pharmacological knowledge. Option C) None and D) All the above are also incorrect as they do not provide accurate information regarding the comparative effectiveness of the two drugs.
Educationally, this question highlights the importance of staying updated on current pharmacological trends and evidence-based practices. It underscores the need for healthcare professionals to critically evaluate medications to make informed decisions for patient care. Understanding the nuances between medications like clofibrate and gemfibrozil can impact treatment outcomes and patient safety, making this knowledge essential for healthcare providers working across the lifespan.
Clofibrate has fallen out of favor due to safety concerns and limited efficacy compared to newer lipid-lowering agents. Gemfibrozil, on the other hand, is a more commonly prescribed fibrate that has shown better outcomes in terms of reducing triglycerides and increasing HDL cholesterol levels.
Option A) TRUE is incorrect because it incorrectly states that clofibrate is superior, which is not supported by current pharmacological knowledge. Option C) None and D) All the above are also incorrect as they do not provide accurate information regarding the comparative effectiveness of the two drugs.
Educationally, this question highlights the importance of staying updated on current pharmacological trends and evidence-based practices. It underscores the need for healthcare professionals to critically evaluate medications to make informed decisions for patient care. Understanding the nuances between medications like clofibrate and gemfibrozil can impact treatment outcomes and patient safety, making this knowledge essential for healthcare providers working across the lifespan.